— Know what they know.
Not Investment Advice

CDXC NASDAQ

ChromaDex Corporation
1W: +9.2% 1M: -21.7% 3M: +16.7% 1Y: +50.1% 3Y: +148.6% 5Y: +76.4%
$7.87
Last traded 2025-04-14 — delisted
NASDAQ · Healthcare · Biotechnology · $611.9M mcap · 51M float · 1.59% daily turnover · Short 36% of daily vol

Balance Sheet Trends

Total Assets
$106M +55.8% ▲
5Y CAGR: +22.6%
Total Liabilities
$30M +34.7% ▲
5Y CAGR: +6.4%
Shareholders Equity
$77M +66.0% ▲
5Y CAGR: +36.0%
Cash & Investments
$65M +45.1% ▲
5Y CAGR: +31.5%
Total Debt
$3M +6.3% ▲
5Y CAGR: +11.5%
Net Debt
-$62M -47.5% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$28M$20M$27M$45M$65M
Short-Term Investments$0$0$152K$0$0
Cash & ST Investments$28M$20M$27M$45M$65M
Net Receivables$5M$8M$5M$8M$10M
Inventory$14M$15M$15M$9M$20M
Other Current Assets$200K$3M$2M$2M$2M
Total Current Assets$49M$47M$50M$64M$97M
Property, Plant & Equip.$7M$6M$5M$2M$2M
Goodwill & Intangibles$857K$671K$510K$359K$6M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$723K$497K$383K$2M$2M
Total Non-Current Assets$9M$7M$5M$4M$10M
Total Assets$58M$54M$55M$68M$106M
— Liabilities —
Accounts Payable$10M$10M$10M$9M$11M
Short-Term Debt$548K$696K$702K$994K$1M
Deferred Revenue$161K$157K$195K$611K$399K
Other Current Liabilities-$548K-$696K-$702K-$994K$19M
Total Current Liabilities$18M$18M$21M$18M$20M
Long-Term Debt$0$0$0$0$2M
Other Non-Current Liab.$4M$4M$0$0$8M
Total Non-Current Liabilities$8M$8M$6M$4M$10M
Total Liabilities$26M$25M$27M$22M$30M
— Equity —
Common Stock$68K$74K$75K$77K$79K
Retained Earnings-$169M-$185M-$190M-$182M-$165M
Accumulated OCI-$2K-$3K-$4K-$4K$0
Total Stockholders Equity$32M$29M$28M$46M$77M
Total Liabilities & Equity$58M$54M$55M$68M$106M
— Key Metrics —
Total Debt$5M$4M$3M$3M$3M
Net Debt-$23M-$16M-$24M-$42M-$62M
Total Investments$0$0$152K$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms